MetLife Investment Management’s CareDx CDNA Stock Holding History

MetLife Investment Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$504K	Sell	29,021 -370	-1%	-$7K	﹤0.01%	1753
2025 Q4	$554K	Sell	29,391 -2,680	-8%	-$44.9K	﹤0.01%	1744
2025 Q3	$466K	Hold	32,071	–	–	﹤0.01%	1840
2025 Q2	$627K	Buy	32,071 +1,333	+4%	+$23.7K	﹤0.01%	1574
2025 Q1	$546K	Sell	30,738 -296	-1%	-$6.38K	﹤0.01%	1689
2024 Q4	$664K	Buy	31,034 +2,134	+7%	+$51.9K	﹤0.01%	1637
2024 Q3	$902K	Sell	28,900 -1,444	-5%	-$35.9K	0.01%	1450
2024 Q2	$471K	Buy	30,344 +2,759	+10%	+$33.3K	﹤0.01%	1748
2024 Q1	$292K	Hold	27,585	–	–	﹤0.01%	1972
2023 Q4	$331K	Hold	27,585	–	–	﹤0.01%	1934
2023 Q3	$193K	Hold	27,585	–	–	﹤0.01%	2233
2023 Q2	$234K	Hold	27,585	–	–	﹤0.01%	2176
2023 Q1	$252K	Hold	27,585	–	–	﹤0.01%	2083
2022 Q4	$315K	Hold	27,585	–	–	﹤0.01%	1949
2022 Q3	$469K	Hold	27,585	–	–	﹤0.01%	1688
2022 Q2	$593K	Hold	27,585	–	–	﹤0.01%	1545
2022 Q1	$1.02M	Buy	27,585 +9,938	+56%	+$387K	0.01%	1308
2021 Q4	$803K	Hold	17,647	–	–	0.01%	1225
2021 Q3	$1.12M	Hold	17,647	–	–	0.01%	1070
2021 Q2	$1.62M	Sell	17,647 -1,254	-7%	-$99.7K	0.01%	957
2021 Q1	$1.29M	Hold	18,901	–	–	0.01%	1025
2020 Q4	$1.37M	Sell	18,901 -1,567	-8%	-$90.8K	0.01%	991
2020 Q3	$777K	Buy	20,468 +1,672	+9%	+$56.5K	0.01%	1154
2020 Q2	$666K	Hold	18,796	–	–	0.01%	1225
2020 Q1	$410K	Hold	18,796	–	–	0.01%	1316
2019 Q4	$405K	Hold	18,796	–	–	﹤0.01%	1573
2019 Q3	$425K	Hold	18,796	–	–	﹤0.01%	1513
2019 Q2	$676K	Buy	18,796 +2,716	+17%	+$86.9K	0.01%	1306
2019 Q1	$507K	Hold	16,080	–	–	0.01%	1445
2018 Q4	$404K	Hold	16,080	–	–	﹤0.01%	1503
2018 Q3	$464K	Hold	16,080	–	–	﹤0.01%	1587
2018 Q2	$197K	Buy	+16,080	New	+$184K	﹤0.01%	1925

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

MetLife Investment Management's CDNA Position: Q1 2026 in Review

MetLife Investment Management reduced its CareDx (CDNA) stake by 1.3% in Q1 2026, selling an estimated $7K and leaving 29,021 shares worth $504K. The position accounts for ﹤0.01% of the portfolio, ranked #1753.

MetLife Investment Management first reported a position in CDNA in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.62M in Q2 2021. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

MetLife Investment Management held 29,021 shares of CareDx worth $504K as of Q1 2026.
MetLife Investment Management sold 370 CareDx shares in Q1 2026, an estimated $7K.
CareDx made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1753 holding.
MetLife Investment Management first reported a position in CareDx in Q2 2018 and has held it in 32 quarters since.
MetLife Investment Management's CareDx position peaked at $1.62M in Q2 2021.
190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.